Document Detail

Placenta previa: an analysis of three years experience.
MedLine Citation:
PMID:  3986026     Owner:  NLM     Status:  MEDLINE    
A retrospective study of 45 cases of complete placenta previa is presented. Expectant management of the premature infant using tocolytics, blood transfusion, and cesarean section was practiced. All patients were suspected of having placenta previa based upon ultrasound examination; 90% reported third-trimester bleeding; 48% required prepartum blood transfusion; and 80% experienced one or more complications. Premature delivery occurred in 67% of patients; tocolysis was initiated in 53%. Patients with previa were older, of higher parity, and more likely to have had a previous cesarean section or abortion than matched controls.
M Sauer; M Parsons; M Sampson
Related Documents :
1825136 - Vaginal birth after cesarean: a meta-analysis of morbidity and mortality.
17150066 - Central fetal monitoring: effect on perinatal outcomes and cesarean section rate.
23388346 - Breast-feeding and formula feeding in healthy term infants and bone health at age 10 ye...
1512646 - Birth weight-specific fetal deaths and neonatal mortality and the rising cesarean secti...
8777656 - Impact of extremely immature infants on neonatal services.
1345466 - Anesthesia for the healthy child.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  American journal of perinatology     Volume:  2     ISSN:  0735-1631     ISO Abbreviation:  Am J Perinatol     Publication Date:  1985 Jan 
Date Detail:
Created Date:  1985-06-17     Completed Date:  1985-06-17     Revised Date:  2005-11-17    
Medline Journal Info:
Nlm Unique ID:  8405212     Medline TA:  Am J Perinatol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  39-42     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Cesarean Section
Magnesium Sulfate / therapeutic use
Obstetric Labor, Premature / prevention & control
Placenta Previa* / complications,  drug therapy,  epidemiology,  etiology
Terbutaline / therapeutic use
Reg. No./Substance:
23031-25-6/Terbutaline; 7487-88-9/Magnesium Sulfate

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  VATER association: analysis of growth and development.
Next Document:  Radiographic clues to chest tube perforation of neonatal lung.